1.本数据库收录EMA集中程序以及经HMA协调通过互认可程序或分权程序获得批准上市的药品
2.查询欧盟成员国上市的相关信息，点击欧盟成员国上市
掌握医院、零售、 电商 三大终端市场的销售脉搏，就用 药品市场全终端分析系统 (←点击链接免费试用)
全面洞察药品零售数据，助力企业精准决策，把握市场增长，就用穿云众客-零售药品消费分析决策系统(←点击链接免费试用)
| 商标名 | 通用名称 | 中文名称 | ATC编码 | 授权日期 | 上市许可持有人 | 市场状态 |
|---|---|---|---|---|---|---|
| Osenvelt | denosumab | 地舒单抗 | M05BX04 | Celltrion Healthcare Hungary Kft. | Opinion | |
| Paxneury | guanfacine | 盐酸胍法辛 | C02AC02 | 2025-02-26 | Neuraxpharm Pharmaceuticals S.L. | Authorised |
| Rytelo | imetelstat | 艾泰司他 | L01XX80 | 2025-03-07 | Geron Netherlands B.V. | Authorised |
| Welireg | belzutifan | 贝组替凡 | L01XX74 | Merck Sharp & Dohme B.V. | Authorised | |
| Yesintek | ustekinumab | 乌司奴单抗 | L04AC05 | 2025-02-14 | Biosimilar Collaborations Ireland Limited | Authorised |
| Zefylti | filgrastim | 非格司亭 | L03AA02 | 2025-02-12 | CuraTeQ Biologics s.r.o | Authorised |
| Seladelpar Gilead | Seladelpar lysine dihydrate | A05AX07 | Gilead Sciences Ireland Unlimited Company | Authorised | ||
| Tuzulby | methylphenidate hydrochloride | 盐酸哌甲酯 | N06BA04 | Neuraxpharm Pharmaceuticals S.L. | Opinion | |
| Datroway | datopotamab deruxtecan | 德达博妥单抗 | L01FX35 | Daiichi Sankyo Europe GmbH | Opinion | |
| Capvaxive | pneumococcal polysaccharide conjugate vaccine (21-valent) | J07AL02 | Merck Sharp & Dohme B.V.xa0 | Opinion | ||
| Datopotamab deruxtecan Daiichi Sankyo | datopotamab deruxtecan | 德达博妥单抗 | L01FX35 | Daiichi Sankyo Europe GmbH | Application withdrawn | |
| Dyrupeg | pegfilgrastim | 培非司亭 | L03AA13 | CuraTeQ Biologics s.r.o | Opinion | |
| Eltrombopag Accord | eltrombopag | 艾曲泊帕乙醇胺 | B02BX05 | Accord Healthcare S.L.U. | Opinion | |
| Pavblu | aflibercept | 阿柏西普 | S01LA05 | Amgen Technology (Ireland) UC | Opinion | |
| Skojoy | aflibercept | 阿柏西普 | S01LA05 | Amgen Technology (Ireland) UC | Application withdrawn | |
| Tivdak | tisotumab vedotin | 维替索妥人单抗 | L01FX23 | Pfizer Europe MA EEIGxa0 | Opinion | |
| Vimkunya | Chikungunya vaccine (recombinant, adsorbed) | Bavarian Nordic A/S | Opinion | |||
| Nugalviq | govorestat | 戈沃瑞司他 | A16AX24 | Advanz Pharma Limited | Application withdrawn | |
| Deqsiga | human normal immunoglobulin | 人免疫球蛋白 | J06BA02 | Takeda Manufacturing Austria AG | Opinion | |
| Vyjuvek | beremagene geperpavec | 戈合贝基 | D03AX16 | Krystal Biotech Netherlands B.V. | Opinion |
